SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending following the announcement of a new high-efficiency solar cell that reduces reliance on germanium, alongside broader optimism as the company advances its end-to-end space strategy. While many traders remain bullish on the long-term potential of the company's space systems and upcoming Neutron rocket, others express frustration over continued stock volatility and dilution concerns.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is receiving significant attention following a strong quarterly earnings report that featured a revenue beat and raised fiscal year guidance, with investors highlighting the company's robust $3B backlog and growth in powertrain solutions as key catalysts. While sentiment is largely bullish, some traders are monitoring the potential impact of share offerings and institutional selling overhangs.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the announcement that the final efficacy analysis of its Phase 3 ORIGIN 3 trial for TRUTAKNA met all prespecified endpoints in treating IgA nephropathy. The community is focused on the drug's potential for full FDA approval and its competitive profile, with many traders speculating on a short squeeze due to high short interest and a tightly held float.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon Enterprise is experiencing significant volatility and downward pressure following heavy insider selling, including by the CEO, alongside broader market concerns about its high valuation and sector rotation. Investors remain divided, with some citing the company's strong growth in AI and defense contracts as a long-term buy opportunity, while others view the stock as overpriced and over-manipulated.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following positive clinical trial data, including Phase 3 SHASTA-3 and SHASTA-4 results for plozasiran, which showed significant reductions in triglycerides and acute pancreatitis events. Traders are closely monitoring the company's commercial progress, clinical readouts, and potential M&A activity despite ongoing debates regarding market maker influence on the stock's price action.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is trending as investors await the upcoming earnings release, with discussion centered on the company's recent production agreement with Sumitomo Chemical for AI datacom and its ongoing development of photonics technology. Traders are weighing the potential for commercial contract announcements against the company's high short interest and limited revenue to date.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's shares dropped significantly after the company reported a surprise second-quarter loss and revenue that missed analyst expectations. While the company expressed optimism regarding ongoing turnaround efforts and improving sales trends, retail sentiment remains divided between those betting on a recovery and others skeptical of the company's long-term financial viability.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as investors weigh concerns about rising Treasury yields—which briefly topped 5%—against the Federal Reserve’s upcoming policy decision. Market participants remain divided, with many debating the impact of a potential rate hike on the tech-heavy index while reacting to industry-wide discourse regarding the pace of AI development.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

Corsair Gaming is receiving attention as traders anticipate upcoming quarterly results, with many highlighting strong recent earnings beats and the company's focus on high-margin peripherals and sim racing. While some express optimism about potential short squeeze dynamics due to high short interest, others remain skeptical, citing concerns over competition and market volatility.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is seeing increased investor focus due to robust commercial growth for its CARVYKTI therapy and speculation regarding a potential buyout, which remains a dominant conversation topic. Traders are debating the company's valuation, the impact of its evolving partnership with Johnson & Johnson, and the potential of its in vivo CAR-T pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
